|
|||||
|
|
Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers |
|
| Authors: | Elaine S Tan MD Biwei Cao MS Jongphil Kim PhD Taymeyah E Al-Toubah MPH Rutika Mehta MD Barbara A Centeno MD Richard D Kim MD |
| Institution: | 1. Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida;2. Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center, Tampa, Florida;3. Department of Pathology, H. Lee Moffitt Cancer Center, Tampa, Florida |
| Abstract: | |
| Keywords: | cholangiocarcinoma copanlisib personalized medicine PI3K targeted therapy |